Inovio Pharmaceuticals, Inc. (INO) stock forecast and price target
Price $1.43 · data as of November 13, 2026
12-month price target
Average target$6.33
Upside / downside+342.9%
Analysts3
ConsensusStrong buy
Low $5.00Average $6.33High $8.00
Gold marker: average target · white marker: today’s price ($1.43)
Analyst ratings
Strong buy 1Buy 2Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.90 | — | $349330 |
| Next fiscal year ends December 31, 2027 | $-0.35 | — | $43M |
| Quarter after ends December 31, 2026 | $-0.10 | — | $6M |
Consensus of the analysts covering Inovio Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Inovio Pharmaceuticals stock price target?
The average 12-month target from 3 analysts is $6.33, 342.9% above the current price of $1.43 Targets range from $5.00 to $8.00.
Is Inovio Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Inovio Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.90 for the fiscal year ending December 31, 2026 and $-0.35 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.